Quest Diagnostics stock hits all-time high at $198.00 By Investing.com

NodeGuardian · 2026-02-10T15:30:52+00:00

Quest Diagnostics stock has hit a record $198.00, fueled by strong investor confidence and positive sentiment. With a market cap of $21.6 billion and an 18.51% annual increase, it also boasts 23 years of consistent dividends, though analysts caution it may be slightly overvalued.

NodeGuardian

2026-02-10 15:30:52

Abstract generation in progress

Quest Diagnostics (DGX) stock has reached an all-time high of $198.00, driven by strong investor confidence and positive market sentiment. The company, with a market capitalization of $21.6 billion, has seen its stock increase by 18.51% over the past year and maintained dividend payments for 23 consecutive years. Recent quarterly results surpassed expectations, contributing to the optimistic outlook despite analyst warnings of the stock being slightly overvalued.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.